Evidence map›Paper›PMID 36674797›Full record

ArticleInternational journal of molecular sciences2023

Suppression of RBFox2 by Multiple MiRNAs in Pressure Overload-Induced Heart Failure.

Mingyao Gu, Yuying Zhao, Hong Wang, Wanwen Cheng, Jie Liu, Kunfu Ouyang, Chaoliang Wei

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mingyao GuShenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis, Health Science Center, Shenzhen University, Shenzhen 518060, China.
Yuying ZhaoShenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis, Health Science Center, Shenzhen University, Shenzhen 518060, China.
Hong WangDepartment of Cardiovascular Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Wanwen ChengDepartment of Pathophysiology, Health Science Center, Shenzhen University, Shenzhen 518060, China.
Jie LiuShenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis, Health Science Center, Shenzhen University, Shenzhen 518060, China.
Kunfu OuyangDepartment of Cardiovascular Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.ORCID 0000-0003-0292-375X
Chaoliang WeiShenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis, Health Science Center, Shenzhen University, Shenzhen 518060, China.
Shenzhen University Health Science Center · CNPeking University Shenzhen Hospital · CN

Funding

National Natural Science Funds of the People's Republic of China 81770227National Natural Science Funds of the People's Republic of China 81970250Shenzhen Basic Research Foundation JCYJ20190808174001746Shenzhen Basic Research Foundation JCYJ20210324105407019Shenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis ZDSYS20190902092903237Shenzhen Science and technology innovation committee project JCYJ20180507182239272
6 · The paper itself

Abstract

Heart failure is the final stage of various cardiovascular diseases and seriously threatens human health. Increasing mediators have been found to be involved in the pathogenesis of heart failure, including the RNA binding protein RBFox2. It participates in multiple aspects of the regulation of cardiac function and plays a critical role in the process of heart failure. However, how RBFox2 itself is regulated remains unclear. Here, we dissected transcriptomic signatures, including mRNAs and miRNAs, in a mouse model of heart failure after TAC surgery. A global analysis showed that an asymmetric alternation in gene expression and a large-scale upregulation of miRNAs occurred in heart failure. An association analysis revealed that the latter not only contributed to the degradation of numerous mRNA transcripts, but also suppressed the translation of key proteins such as RBFox2. With the aid of Ago2 CLIP-seq data, luciferase assays verified that RBFox2 was targeted by multiple miRNAs, including Let-7, miR-16, and miR-200b, which were significantly upregulated in heart failure. The overexpression of these miRNAs suppressed the RBFox2 protein and its downstream effects in cardiomyocytes, which was evidenced by the suppressed alternative splicing of the Enah gene and impaired E-C coupling via the repression of the Jph2 protein. The inhibition of Let-7, the most abundant miRNA family targeting RBFox2, could restore the RBFox2 protein as well as its downstream effects in dysfunctional cardiomyocytes induced by ISO treatment. In all, these findings revealed the molecular mechanism leading to RBFox2 depression in heart failure, and provided an approach to rescue RBFox2 through miRNA inhibition for the treatment of heart failure.

Indexed as

Heart FailureMicroRNAsAlternative SplicingAnimalsHumansMiceRepressor ProteinsRNA-Binding ProteinsRNA, MessengerRNA Splicing FactorsMicroRNAsRBFOX2 protein, humanRbfox2 protein, mouseRepressor ProteinsRNA-Binding ProteinsRNA, MessengerRNA Splicing Factorsalternative splicingE–C couplingheart failuremiRNAsRBFox2

Identifiers

PMID36674797
PMCPMC9867119
OpenAlexW4313890339

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.